DrugPatentWatch Database Preview
Details for Biologics License Application: 103575
Email this page to a colleague
See Plans and PricingSummary for BLA: 103575
| Tradename: | REOPRO |
| Applicant: | Centocor Inc |
| Ingredient: | abciximab |
| Patents: | 201 |
| Approval Date: | Dec 22, 1994 |
| Suppliers: see list | 1 |
US Patents for BLA: 103575
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | HemoSonics LLC (Charlottesville, VA) | 2031-02-15 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | INSPIREMD, LTD. (IL) | 2025-05-24 | RX | search | |
| Centocor Inc | REOPRO | abciximab | INJECTABLE; INJECTION | 103575 | 001 | 1994-12-22 | Start Trial | LOCAL PHARMA, INC. (Las Vegas, NV) | 2028-01-09 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
